Phosphorylation of BRCA2 by the Polo-like kinase Plk1 is regulated by DNA damage and mitotic progression

Oncogene

Volumn 23, Issue 4, 2004, Pages 865-872

  Lee, MiYoung ^a   Daniels, Matthew J ^a   Venkitaraman, Ashok R ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

BRCA2; DNA repair; Mitosis; Polo

Indexed keywords

BREAST CANCER SUSCEPTIBILITY PROTEIN 2; DOXORUBICIN; PHOSPHOTRANSFERASE; POLO LIKE KINASE 1; PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; CELL CYCLE G2 PHASE; CONTROLLED STUDY; DNA DAMAGE; EMBRYO; ENZYME ACTIVITY; ENZYME DEFICIENCY; FEMALE; HUMAN; HUMAN CELL; METAPHASE; MITOSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN MODIFICATION; PROTEIN MOTIF; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; REGULATORY MECHANISM;

BASE SEQUENCE; BLOTTING, WESTERN; BRCA2 PROTEIN; CELL CYCLE PROTEINS; CELL LINE; DNA DAMAGE; DNA PRIMERS; HUMANS; MITOSIS; PHOSPHORYLATION; PROTEIN KINASES; PROTEIN-SERINE-THREONINE KINASES; PROTO-ONCOGENE PROTEINS;

EID: 1342280371     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1207223     Document Type: Article

References (41)

1. Abrieu A, Brassac T, Galas S, Fisher D, Labbe JC and Doree M. (1998). J. Cell. Sci., 111 (Part 12), 1751-1757.
2. Alexandru G, Uhlmann F, Mechtler K, Poupart MA and Nasmyth K. (2001). Cell, 105, 459-472.
3. Baumann P, Benson FE and West SC. (1996). Cell, 87, 757-766.
4. Bertwistle D and Ashworth A. (1998). Curr. Opin. Genet. Dev., 8, 14-20.
5. Bork P, Blomberg N and Nilges M. (1996). Nat. Genet., 13, 22-23.
6. Chen PL, Chen CF, Chen Y, Xiao J, Sharp ZD and Lee WH. (1998a). Proc. Natl. Acad. Sci. USA, 95, 5287-5292.
7. Chen J, Silver DP, Walpita D, Cantor SB, Gazdar AF, Tomlinson G, Couch FJ, Weber BL, Ashley T, Livingston DM and Scully R. (1998b). Mol. Cell, 2, 317-328.
8. Connor F, Bertwistle D, Mee PJ, Ross GM, Swift S, Grigorieva E, Tybulewicz VL and Ashworth A. (1997). Nat. Genet., 17, 423-430.
9. Davies AA, Masson JY, McIlwraith MJ, Stasiak AZ, Stasiak A, Venkitaraman AR and West SC. (2001). Mol. Cell, 7, 273-282.
10. Glover DM, Hagan IM and Tavares AA. (1998). Genes Dev., 12, 3777-3787.
11. Hamanaka R, Smith MR, O'Connor PM, Maloid S, Mihalic K, Spivak JL, Longo DL and Ferris DK. (1995). J. Biol. Chem., 270, 21086-21091.
12. Lee KS, Yuan YL, Kuriyama R and Erikson RL. (1995). Mol. Cell. Biol., 15, 7143-7151.
13. Losada A, Hirano M and Hirano T. (2002). Genes Dev., 16, 3004-3016.
14. Marmorstein LY, Kinev AV, Chan GK, Bochar DA, Beniya H, Epstein JA, Yen TJ and Shiekhattar R. (2001). Cell, 104, 247-257.
15. Milner J, Fuks F, Hughes-Davies L and Kouzarides T. (2000). Oncogene, 19, 4441-4445.
16. Nigg EA. (1998). Curr. Opin. Cell. Biol., 10, 776-783.
17. Patel KJ, Yu VP, Lee H, Corcoran A, Thistlethwaite FC, Evans MJ, Colledge WH, Friedman LS, Ponder BA and Venkitaraman AR. (1998). Mol. Cell, 1, 347-357.
18. Pellegrini L, Yu DS, Lo T, Anand S, Lee M, Blundell TL and Venkitaraman AR. (2002). Nature, 420, 287-293.
19. Qian YW, Erikson E and Maller JL. (1999). Mol. Cell. Biol., 19, 8625-8632.
20. Qian YW, Erikson E, Taieb FE and Maller JL. (2001). Mol. Biol. Cell., 12, 1791-1799.
21. Roshak AK, Capper EA, Imburgia C, Fornwald J, Scott G and Marshall LA. (2000). Cell Signal, 12, 405-411.
22. Smits VA, Klompmaker R, Arnaud L, Rijksen G, Nigg EA and Medema RH. (2000). Nat. Cell. Biol., 2, 672-676.
23. Sumara I, Vorlaufer E, Stukenberg PT, Kelm O, Redemann N, Nigg EA and Peters JM. (2002). Mol. Cell., 9, 515-525.
24. Sung P. (1994). Science, 265, 1241-1243.
25. Suzuki A, de la Pompa JL, Hakem R, Elia A, Yoshida R, Mo R, Nishina H, Chuang T, Wakeham A, Itie A, Koo W, Billia P, Ho A, Fukumoto M, Hui CC and Mak TW. (1997). Genes Dev., 11, 1242-1252.
26. Takahashi T, Sano B, Nagata T, Kato H, Sugiyama Y, Kunieda K, Kimura M, Okano Y and Saji S. (2003). Cancer Sci., 94, 148-152.
27. Takai N, Miyazaki T, Fujisawa K, Nasu K, Hamanaka R and Miyakawa I. (2001a). Cancer Lett., 169, 41-49.
28. Takai N, Miyazaki T, Fujisawa K, Nasu K, Hamanaka R and Miyakawa I. (2001b). Cancer Lett., 164, 41-49.
29. Tokumitsu Y, Mori M, Tanaka S, Akazawa K, Nakano S and Niho Y. (1999). Int. J. Oncol., 15, 687-692.
30. Toyoshima-Morimoto F, Taniguchi E and Nishida E. (2002). EMBO Rep., 3, 341-348.
31. Tutt A, Gabriel A, Bertwistle D, Connor F, Paterson H, Peacock J, Ross G and Ashworth A. (1999). Curr. Biol., 9, 1107-1110.
32. Uchiumi T, Longo DL and Ferris DK. (1997). J. Biol. Chem., 272, 9166-9174.
33. van Vugt MA, Smits VA, Klompmaker R and Medema RH. (2001). J. Biol. Chem., 276, 41656-41660.
34. Venkitaraman AR. (2000). Philos. Trans. Roy. Soc. London B Biol. Sci., 355, 191-198.
35. Venkitaraman AR. (2002). Cell, 108, 171-182.
36. Weitzer S and Uhlmann F. (2002). Dev. Cell, 2, 381-382.
37. Wolf G, Elez R, Doermer A, Holtrich U, Ackermann H, Stutte HJ, Altmannsberger HM, Rubsamen-Waigmann H and Strebhardt K. (1997). Oncogene, 14, 543-549.
38. Wolf G, Hildenbrand R, Schwar C, Grobholz R, Kaufmann M, Stutte HJ, Strebhardt K and Bleyl U. (2000). Pathol. Res. Pract., 196, 753-759.
39. Wong AK, Pero R, Ormonde PA, Tavtigian SV and Bartel PL. (1997). J. Biol. Chem., 272, 31941-31944.
40. Wu K, Jiang SW and Couch FJ. (2003). J. Biol. Chem., 278, 15652-15656.
41. Yu VP, Koehler M, Steinlein C, Schmid M, Hanakahi LA, van Gool AJ, West SC and Venkitaraman AR. (2000). Genes Dev., 14, 1400-1406.